Market Cap 97.43M
Revenue (ttm) 351.41M
Net Income (ttm) 880,000.00
EPS (ttm) N/A
PE Ratio 0.00
Forward PE 4.21
Profit Margin 0.25%
Debt to Equity Ratio -1.15
Volume 2,961,500
Avg Vol 3,291,444
Day's Range N/A - N/A
Shares Out 161.82M
Stochastic %K 18%
Beta 0.24
Analysts Hold
Price Target $0.92

Latest News on IRWD

Ironwood Pharmaceuticals Reports First Quarter 2025 Results

May 7, 2025, 7:05 AM EDT - 4 weeks ago

Ironwood Pharmaceuticals Reports First Quarter 2025 Results


Ironwood Pharmaceuticals Reports Third Quarter 2024 Results

Nov 7, 2024, 7:00 AM EST - 7 months ago

Ironwood Pharmaceuticals Reports Third Quarter 2024 Results


Ironwood Pharmaceuticals Reports Second Quarter 2024 Results

Aug 8, 2024, 7:00 AM EDT - 10 months ago

Ironwood Pharmaceuticals Reports Second Quarter 2024 Results


Ironwood Pharmaceuticals: Q3 Of 2024 Data Readout For PBC

Jun 20, 2024, 1:00 PM EDT - 1 year ago

Ironwood Pharmaceuticals: Q3 Of 2024 Data Readout For PBC